Our data showed that sequential down-regulation of ZG16 from early precancerous lesions to adenocarcinoma was associated with the molecular phenotypes of these tumors being MSI-H and CIMP-H, and/or exhibiting MLH1 silencing. The gene discussed is MLH1; the disease is adenocarcinoma.